Skip to content
HowShorted

Monopar Therapeutics short interest in 2022

In 2022, Monopar Therapeutics's disclosed short interest ran from 0.16% of shares outstanding on 14 Jan 2022 to 0.21% on 15 Dec 2022, a change of +0.05 percentage points. The year's high was 0.32% on 30 Nov 2022 and its low 0.02% on 15 Mar 2022, averaging 0.10% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.55 days on 30 Nov 2022. Full history: Monopar Therapeutics.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Monopar Therapeutics in 2022

2022 in figures

Start of year
0.16% (14 Jan 2022)
End of year
0.21% (15 Dec 2022)
Change
+0.05 pp
High
0.32% (30 Nov 2022)
Low
0.02% (15 Mar 2022)
Average
0.10%
Highest days to cover
2.55 (30 Nov 2022)
SEC filings marked
8

Every report in 2022

Monopar Therapeutics short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20220.16%1.00
31 Jan 20220.14%2.01
15 Mar 20220.02%1.00
31 Mar 20220.05%1.0010-K filed, results (8-K)
14 Apr 20220.02%1.79
29 Apr 20220.03%1.00
13 May 20220.02%1.0010-Q filed, results (8-K)
15 Jun 20220.05%1.00
30 Jun 20220.06%1.00
15 Jul 20220.05%1.70
29 Jul 20220.07%1.05
31 Aug 20220.06%1.1610-Q filed, results (8-K)
15 Sep 20220.09%1.00
30 Sep 20220.14%1.88
14 Oct 20220.09%1.00
31 Oct 20220.13%2.33
15 Nov 20220.25%1.0010-Q filed, results (8-K)
30 Nov 20220.32%2.55
15 Dec 20220.21%1.00

See also: Monopar Therapeutics's full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.